Shih YC - Search Results

1

Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.

Shih YC, Bekele NB, Xu Y. Shih YC, et al. Pharmacoeconomics. 2007;25(10):843-62. doi: 10.2165/00019053-200725100-00004. Pharmacoeconomics. 2007. PMID: 17887806

2

Octreotide long-acting repeatable use among elderly patients with carcinoid syndrome and survival outcomes: a population-based analysis.

Shen C, Shih YC, Xu Y, Yao JC. Shen C, et al. Among authors: shih yc. Cancer. 2014 Jul 1;120(13):2039-49. doi: 10.1002/cncr.28653. Epub 2014 Mar 26. Cancer. 2014. PMID: 24676892 Free article.

3

Octreotide long-acting repeatable among elderly patients with neuroendocrine tumors: a survival analysis of SEER-Medicare data.

Shen C, Shih YC, Xu Y, Yao JC. Shen C, et al. Among authors: shih yc. Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1656-65. doi: 10.1158/1055-9965.EPI-15-0336. Epub 2015 Aug 27. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26315553

4

Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors.

Shen C, Xu Y, Dasari A, Shih YC, Yao JC. Shen C, et al. Among authors: shih yc. Oncologist. 2016 Mar;21(3):308-13. doi: 10.1634/theoncologist.2015-0381. Epub 2016 Feb 24. Oncologist. 2016. PMID: 26911407 Free PMC article.

5

Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.

Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS. Shih YC, et al. J Clin Oncol. 2009 Apr 20;27(12):2007-14. doi: 10.1200/JCO.2008.18.3517. Epub 2009 Mar 16. J Clin Oncol. 2009. PMID: 19289624

6

Comparative effectiveness, cost, and utilization of radical prostatectomy among young men within managed care insurance plans.

Shih YC, Ward JF, Pettaway CA, Xu Y, Matin SF, Davis JW, Thompson BP, Elting LS. Shih YC, et al. Value Health. 2012 Mar-Apr;15(2):367-75. doi: 10.1016/j.jval.2011.10.008. Epub 2011 Dec 16. Value Health. 2012. PMID: 22433769 Free article.

7

Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in Taiwan.

Shih YC, Pan IW, Tsai YW. Shih YC, et al. Pharmacoeconomics. 2009;27(11):947-61. doi: 10.2165/11314110-000000000-00000. Pharmacoeconomics. 2009. PMID: 19888794

8

Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer.

Smith GL, Xu Y, Buchholz TA, Giordano SH, Jiang J, Shih YC, Smith BD. Smith GL, et al. Among authors: shih yc. JAMA. 2012 May 2;307(17):1827-37. doi: 10.1001/jama.2012.3481. JAMA. 2012. PMID: 22550197 Free PMC article.

9

A population-based study of the quality of care in the diagnosis of large (≥5 cm) soft tissue sarcomas.

Guadagnolo BA, Xu Y, Zagars GK, Cormier JN, Pollock RE, Feig BW, Giordano S, Buchholz TA, Shih YC. Guadagnolo BA, et al. Among authors: shih yc. Am J Clin Oncol. 2012 Oct;35(5):455-61. doi: 10.1097/COC.0b013e3182185873. Am J Clin Oncol. 2012. PMID: 21537147

10

Impact of generic drug entry on cost-effectiveness analysis.

Shih YC, Han S, Cantor SB. Shih YC, et al. Med Decis Making. 2005 Jan-Feb;25(1):71-80. doi: 10.1177/0272989X04273139. Med Decis Making. 2005. PMID: 15673583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters